Patents by Inventor Eok Park

Eok Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL BICYCLIC HETEROARYL COMPOUND AND USE THEREOF
    Publication number: 20250388582
    Abstract: The present invention provides a novel compound represented by Chemical Formula 1, an optical isomer thereof, or a pharmaceutically acceptable salt thereof. With an excellent inhibitory activity against PIKfyve, the novel compound of the present invention is useful as a therapeutic agent for PIKfyve activity-related cancer disease, inflammatory disease, or lysosomal storage disease.
    Type: Application
    Filed: July 12, 2023
    Publication date: December 25, 2025
    Inventors: Sunyoung Park, Hyojung Song, Kyusic Jang, Min Whan Chang, Minkyung Kim, Il Ji Jeong, Jongha Lim, Jisu Yoo, Woojin Jeon, Yoonsung Song, Hong Chul Yoon, Joon Tae Park, Jung Woo Lee, Kyung Mi An, Dongsik Park, Dasol Kim, Weonbin Im, So-Young Eun, Byong-Keol Min, Hong Jae Lee, Eunjung Kim, Eok Park
  • PHARMACEUTICALLY ACTIVE COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING PENDRIN
    Publication number: 20250340537
    Abstract: The present invention relates to a novel compound as pendrin corrector represented by the following Chemical formula 1 and a composition for preventing or treating pendred syndrome and the related disease thereof comprising the same as an active ingredient:
    Type: Application
    Filed: December 29, 2023
    Publication date: November 6, 2025
    Inventors: Jae Young CHOI, Gyoon Hee HAN, Min Goo LEE, Wan NAMKUNG, Jinsei JUNG, Sungwoo CHO, Shinhye NOH, Doona SONG, Dongsik PARK, Hong Jae LEE, Weonbin IM, So-Young EUN, Eok PARK, Mihwa SHIN
  • NOVEL COMPOUND HAVING INHIBITORY ACTIVITY AGAINST PENDRIN, AND PHARMACEUTICAL USES THEREOF
    Publication number: 20240287042
    Abstract: The present invention relates to a novel compound having inhibitory activity against pendrin, and pharmaceutical uses thereof, and provides a compound represented by formula 1 below, an E- or Z-isomer thereof, an optical isomer thereof, a precursor thereof, a pharmaceutically acceptable salt thereof, a solvate thereof or a mixture of two or more isomers thereof, and a composition for preventing, relieving or treating respiratory diseases and a diuretic composition, each composition utilizing the inhibitory activity of the compound against pendrin.
    Type: Application
    Filed: June 10, 2022
    Publication date: August 29, 2024
    Inventors: Jae Young CHOI, Gyoonhee HAN, Wan NAMKUNG, Moo Suk PARK, Sungha PARK, Tae-Hyun YOO, Junyoung PARK, Weonbin IM, Eok PARK, Chunwon JUNG, Byong-Keol MIN, Taewon KIM, Seoyoung CHOI
  • Indole and indazole compounds as an inhibitor of cellular necrosis
    Patent number: 9000028
    Abstract: The present invention relates to indole or indazole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole or indazole compounds as an active ingredient.
    Type: Grant
    Filed: April 9, 2013
    Date of Patent: April 7, 2015
    Assignee: LG Life Sciences Ltd.
    Inventors: Soon Ha Kim, Hyoung Jin Kim, Sun Young Koo, Chul Woong Chung, Sung Bae Lee, Heui Sul Park, Seung Hyun Yoon, Hyo Shin Kwak, Dong Ook Seo, Eok Park
  • Indole compounds as an inhibitor of cellular necrosis
    Patent number: 8889691
    Abstract: The present invention relates to new indole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole compounds as an active ingredient.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: November 18, 2014
    Assignee: LG Life Sciences Ltd.
    Inventors: Soon Ha Kim, Hyoung Jin Kim, Sun Young Koo, Sung Bae Lee, Heui Sul Park, Seung Hyun Yoon, Seung Yup Paek, Hyo Shin Kwak, Dong Ook Seo, Eok Park
  • INDOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS
    Publication number: 20140024618
    Abstract: The present invention relates to new indole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole compounds as an active ingredient.
    Type: Application
    Filed: September 23, 2013
    Publication date: January 23, 2014
    Applicant: LG LIFE SCIENCES LTD.
    Inventors: Soon Ha KIM, Hyoung Jin KIM, Sun Young KOO, Sung Bae LEE, Heui Sul PARK, Seung Hyun YOON, Seung Yup PAEK, Hyo Shin KWAK, Dong Ook SEO, Eok PARK
  • Indole compounds as an inhibitor of cellular necrosis
    Patent number: 8569307
    Abstract: The present invention relates to new indole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole compounds as an active ingredient.
    Type: Grant
    Filed: June 11, 2012
    Date of Patent: October 29, 2013
    Assignee: LG Life Sciences Ltd.
    Inventors: Soon Ha Kim, Hyoung Jin Kim, Sun Young Koo, Sung Bae Lee, Heui Sul Park, Seung Hyun Yoon, Seung Yup Paek, Hyo Shin Kwak, Dong Ook Seo, Eok Park
  • INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS
    Publication number: 20130237532
    Abstract: The present invention relates to indole or indazole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole or indazole compounds as an active ingredient.
    Type: Application
    Filed: April 9, 2013
    Publication date: September 12, 2013
    Applicant: LG Life Sciences Ltd.
    Inventors: Soon Ha KIM, Hyoung Jin KIM, Sun Young KOO, Chul Woong CHUNG, Sung Bae LEE, Heui Sul PARK, Seung Hyun YOON, Hyo Shin KWAK, Dong Ook SEO, Eok PARK
  • Indole and indazole compounds as an inhibitor of cellular necrosis
    Patent number: 8436038
    Abstract: The present invention relates to indole or indazole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole or indazole compounds as an active ingredient.
    Type: Grant
    Filed: August 18, 2008
    Date of Patent: May 7, 2013
    Assignee: LG Life Sciences Ltd.
    Inventors: Soon Ha Kim, Hyoung Jin Kim, Sun Young Koo, Chul Woong Chung, Sung Bae Lee, Heui Sul Park, Seung Hyun Yoon, Hyo Shin Kwak, Dong Ook Seo, Eok Park
  • INDOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS
    Publication number: 20120252798
    Abstract: The present invention relates to new indole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole compounds as an active ingredient.
    Type: Application
    Filed: June 11, 2012
    Publication date: October 4, 2012
    Inventors: Soon Ha KIM, Hyoung Jin Kim, Sun Young Koo, Sung Bae Lee, Heui Sul Park, Seung Hyun Yoon, Seung Yup Paek, Hyo Shin Kwak, Dong Ook Seo, Eok Park
  • Indole compounds as an inhibitor of cellular necrosis
    Patent number: 8222414
    Abstract: The present invention relates to new indole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole compounds as an active ingredient.
    Type: Grant
    Filed: August 18, 2008
    Date of Patent: July 17, 2012
    Assignee: LG Life Sciences Ltd.
    Inventors: Soon Ha Kim, Hyoung Jin Kim, Sun Young Koo, Sung Bae Lee, Heui Sul Park, Seung Hyun Yoon, Seung Yup Paek, Hyo Shin Kwak, Dong Ook Seo, Eok Park
  • INDOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS
    Publication number: 20100210647
    Abstract: The present invention relates to new indole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole compounds as an active ingredient.
    Type: Application
    Filed: August 18, 2008
    Publication date: August 19, 2010
    Applicant: LG Life Sciences Ltd.
    Inventors: Soon Ha Kim, Hyoung Jin Kim, Sun Young Koo, Sung Bae Lee, Heui Sul Park, Seung Hyun Yoon, Seung Yup Paek, Hyo Shin Kwak, Dong Ook Seo, Eok Park
  • INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS
    Publication number: 20100197673
    Abstract: The present invention relates to indole or indazole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole or indazole compounds as an active ingredient.
    Type: Application
    Filed: August 18, 2008
    Publication date: August 5, 2010
    Applicant: LG Life Sciences Ltd
    Inventors: Soon Ha Kim, Hyoung Jin Kim, Sun Young Koo, Chul Woong Chung, Sung Bae Lee, Heui Sul Park, Seung Hyun Yoon, Hyo Shin Kwak, Dong Ook Seo, Eok Park